Notably, recurrent gene fusions of the 5′ untranslated region of TMPRSS2 to the transcription factor ERG is the most frequent genomic alteration in early- and late-stage prostate cancer and results in overexpression of ERG. The gene discussed is ERG; the disease is prostate carcinoma.